CRGX
Price
$4.54
Change
+$0.08 (+1.79%)
Updated
Aug 15 closing price
Capitalization
219.57M
88 days until earnings call
EVAX
Price
$2.88
Change
+$0.02 (+0.70%)
Updated
Aug 15 closing price
Capitalization
18.19M
Interact to see
Advertisement

CRGX vs EVAX

Header iconCRGX vs EVAX Comparison
Open Charts CRGX vs EVAXBanner chart's image
CARGO Therapeutics
Price$4.54
Change+$0.08 (+1.79%)
Volume$1.61M
Capitalization219.57M
Evaxion A/S
Price$2.88
Change+$0.02 (+0.70%)
Volume$28.28K
Capitalization18.19M
CRGX vs EVAX Comparison Chart in %
Loading...
CRGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EVAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRGX vs. EVAX commentary
Aug 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRGX is a Hold and EVAX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 16, 2025
Stock price -- (CRGX: $4.54 vs. EVAX: $2.88)
Brand notoriety: CRGX and EVAX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRGX: 89% vs. EVAX: 28%
Market capitalization -- CRGX: $219.57M vs. EVAX: $18.19M
CRGX [@Biotechnology] is valued at $219.57M. EVAX’s [@Biotechnology] market capitalization is $18.19M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.71B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRGX’s FA Score shows that 1 FA rating(s) are green whileEVAX’s FA Score has 1 green FA rating(s).

  • CRGX’s FA Score: 1 green, 4 red.
  • EVAX’s FA Score: 1 green, 4 red.
According to our system of comparison, EVAX is a better buy in the long-term than CRGX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRGX’s TA Score shows that 3 TA indicator(s) are bullish while EVAX’s TA Score has 4 bullish TA indicator(s).

  • CRGX’s TA Score: 3 bullish, 3 bearish.
  • EVAX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both CRGX and EVAX are a good buy in the short-term.

Price Growth

CRGX (@Biotechnology) experienced а +1.11% price change this week, while EVAX (@Biotechnology) price change was +1.77% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.90%. For the same industry, the average monthly price growth was +26.70%, and the average quarterly price growth was +20.91%.

Reported Earning Dates

CRGX is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Biotechnology (+9.90% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRGX($220M) has a higher market cap than EVAX($18.2M). EVAX YTD gains are higher at: -31.867 vs. CRGX (-68.516). EVAX has higher annual earnings (EBITDA): -12.99M vs. CRGX (-162.4M). CRGX has more cash in the bank: 319M vs. EVAX (17.8M). EVAX has less debt than CRGX: EVAX (10.5M) vs CRGX (30.4M). EVAX has higher revenues than CRGX: EVAX (3.29M) vs CRGX (0).
CRGXEVAXCRGX / EVAX
Capitalization220M18.2M1,209%
EBITDA-162.4M-12.99M1,250%
Gain YTD-68.516-31.867215%
P/E RatioN/AN/A-
Revenue03.29M-
Total Cash319M17.8M1,792%
Total Debt30.4M10.5M290%
TECHNICAL ANALYSIS
Technical Analysis
CRGXEVAX
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
Momentum
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 9 days ago
89%
Bullish Trend 4 days ago
83%
Declines
ODDS (%)
Bearish Trend 5 days ago
79%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
85%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
69%
View a ticker or compare two or three
Interact to see
Advertisement
CRGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EVAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SZHFF21.50N/A
N/A
Sojitz Corp.
TAGP0.03N/A
N/A
Tristar Acquisition Group
ARRJF3.07N/A
N/A
Arjo AB
IMBBF41.40-0.20
-0.48%
Imperial Brands PLC
TRVR33.61-0.93
-2.69%
Two Rivers Financial Group, Inc.

CRGX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRGX has been loosely correlated with IKT. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if CRGX jumps, then IKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRGX
1D Price
Change %
CRGX100%
+1.79%
IKT - CRGX
42%
Loosely correlated
+2.34%
ALLO - CRGX
41%
Loosely correlated
+2.80%
CRNX - CRGX
39%
Loosely correlated
+3.47%
PRME - CRGX
38%
Loosely correlated
-1.92%
CELC - CRGX
37%
Loosely correlated
-0.19%
More

EVAX and

Correlation & Price change

A.I.dvisor tells us that EVAX and LPTX have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EVAX and LPTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EVAX
1D Price
Change %
EVAX100%
+0.70%
LPTX - EVAX
31%
Poorly correlated
+10.06%
KURA - EVAX
31%
Poorly correlated
+11.21%
HYPD - EVAX
28%
Poorly correlated
+7.62%
CRGX - EVAX
27%
Poorly correlated
+1.79%
KYTX - EVAX
27%
Poorly correlated
-0.85%
More